Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
Allison L. Naleway(Centers for Disease Control and Prevention), Elyse O. Kharbanda(HealthPartners), Matthew F. Daley(Kaiser Permanente), Ousseny Zerbo(Kaiser Permanente), David L. McClure(Marshfield Clinic), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Sungching Glenn, Nicola P. Klein, Catherine A. Panozzo(Harvard University), Stephanie A. Irving(Kaiser Permanente Center for Health Research), Natalie McCarthy(Centers for Disease Control and Prevention), Lakshmi Panagiotakopoulos(Centers for Disease Control and Prevention), Eric Weintraub, Simon J. Hambidge, Gabriela Vazquez‐Benitez, Don Bachman(Kaiser Permanente Center for Health Research), Kimberly K. Vesco(Kaiser Permanente), Bradley Crane, Darios Getahun(Kaiser Permanente)
Cited by 49
Related Papers
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602